Joseph Larosa - May 21, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Stock symbol
REGN
Transactions as of
May 21, 2024
Transactions value $
-$1,855,489
Form type
4
Date filed
5/22/2024, 04:02 PM
Previous filing
Feb 28, 2024
Next filing
Jun 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$1.86 M -1.87 K -5.1% $994.90 34.7 K May 21, 2024 Direct F1
holding REGN Common Stock 3.37 K May 21, 2024 2022 GRAT
holding REGN Common Stock 371 May 21, 2024 By 401(k) Plan

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2024.